health_en

Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research

Lifebit today announces a long-term partnership where Lifebit’s technology, Lifebit CloudOS, will power a cloud-based Trusted Research Environment (TRE) to serve as the scalable and secure data management and analysis platform for researchers at the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre (BRC). As one of the leading UK biomedical research organisations, […]

thaipr.net

26 ม.ค. 65

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

Concept Medical Inc., focused on vascular intervention drug delivery devices, shares the latest status of its IMPRESSION (sIroliMus coated balloon angioPlasty versus plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION) randomized controlled trial (RCT), as it crosses the 50 per cent enrollment mark. IMPRESSION randomized trial enrolled its index patient on January 11, 2021 […]

thaipr.net

26 ม.ค. 65

Swiss Pharma Company – IDEOGEN takes over Special Access Program for BELEODAQ® (belinostat)

IDEOGEN GROUP, Managed Access division, takes over Special Access Program for BELEODAQ® (belinostat) in Europe, Middle East, North Africa, Russia, and CIS. BELEODAQ® is a prescription medicine used to treat patients with a rare form of blood cancer called peripheral T-cell lymphoma (PTCL) that relapsed or does not respond to previous treatment. PTCL is a group of rare […]

thaipr.net

24 ม.ค. 65

Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers

Applied Pharmaceutical Science, Inc. (“APS” or “the Company”), has recently announced the Investigational New Drug (IND) application for its self-developed breakthrough new drug APS03118, a next generation selective RET inhibitor, has been approved by the U.S. Food and Drug Administration (FDA). The clinical application is also in the process of being submitted to the National […]

thaipr.net

24 ม.ค. 65

Victor Papamoniodis Joins Medison Pharma as VP International Markets

Medison, a global pharma company focused on providing access to highly innovative therapies to patients in international markets (“Medison”), is proud to announce the joining of Victor Papamoniodis in the newly created position of VP International Markets. Victor will be based in Zug, Switzerland, Medison’s international headquarters. Victor will head Medison’s markets outside of Israel and will focus on scaling…

thaipr.net

21 ม.ค. 65

Sputnik V demonstrates strong protection against Omicron variant, with over 2 times higher virus neutralizing activity compared to the Pfizer vaccine according to a unique independent comparative study conducted by the Spallanzani Institute in Italy

Previous studies also demonstrated additional significant strengthening of protection against Omicron by Sputnik Light booster, which can also be a universal booster to other vaccines to strengthen and lengthen their protection against Omicron. A unique comparative study conducted at the Italian Spallanzani Institute, the leading Italian research institute for infectious diseases, by a joint Italian-Russian […]

thaipr.net

21 ม.ค. 65

Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray in Singapore, Hong Kong and Vietnam

Under the terms of the agreement, Glenmark will be responsible for the manufacture and supply of Ryaltris™, while Lotus International Pte. Ltd. will be responsible for the commercialization of Ryaltris™ (subject to receipt of regulatory approvals) across these markets. Glenmark will receive an upfront payment as well as regulatory and sales based milestone payments from […]

thaipr.net

21 ม.ค. 65

Accomplished Pharma R&D leader, Sauri Gudlavalleti joins Sai Life Sciences as Chief Operating Officer

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO-CDMO), today announced the appointment of Sauri Gudlavalleti as its Chief Operating Officer. Sauri will report to the CEO & Managing Director, Krishna Kanumuri and drive the company’s growth as a new generation, science-driven organization. Making the announcement, Krishna Kanumuri said, “I am really excited to welcome…

thaipr.net

20 ม.ค. 65
1 … 82 83 84 85 86 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.